Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors

Anticancer Research

Volumn 16, Issue 3 A, 1996, Pages 1101-1106

  Gagliardi, Antonio R ^a,b   Hennig, Bernhard ^c   Collins, Delwood C ^a,b,d  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Angiogenic growth factors; Antiestrogens; Endothelial cells; Nafoxidine; Tamoxifen

Indexed keywords

ANGIOGENIC FACTOR; ANTIESTROGEN; BASIC FIBROBLAST GROWTH FACTOR; CLOMIFENE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; NAFOXIDINE; TAMOXIFEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SKIN BLOOD VESSEL; SWINE; VASCULAR ENDOTHELIUM;

ANIMALS; CELL DIVISION; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ESTROGEN ANTAGONISTS; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; PULMONARY ARTERY; SKIN; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029900401     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lippman M, Bolan G and Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595-4601, 1976.
2. Jordan VC, Collins MM, Rowsby L and Prestwich. G: A monohydroxylated metabolite of tamoxifen with potent anti-oestrogenic activity. J Endocr 75: 305-316, 1977.
3. Reddel RR, Murphy LC, Hall RE and Sutherland RL: Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res 45: 1512-1531, 1985.
4. Green MD, Murphy LC, Whybourne AM and Sutherland RL: Nonsteroidal antiestrogens: Molecular pharmacology and antitumor actions. (Sutherland RL and Jordan VC. eds.), Sydney, Australia, Academic Press, 1981. pp 397-411.
5. Hawkins RA, Roberts MM and Forrest APM: Oestrogen receptors and breast cancer: current status. Brit J Surg 67: 153-169, 1980.
6. Furr BJ and Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmac Ther 25: 127-205, 1984.
7. Butta A, MacLennan K, Flanders KC, Sacks NPM, Smith I, McKinna A, Dowsett M, Wakefield LM, Sporn MB, Baum M and Colletta AA: Induction of transforming growth factor B1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res 52 4261-4264, 1992.
8. Pollak M, Costantino J, Polychronakos C, Blauer S-A, Guyda H, Redmond C, Fisher B and Margolese R: Effect of tamoxifen on serum insulinlike growth factor 1 levels in stage 1 breast cancer patients. J Natl Cancer Res Inst 82: 1693-1697, 1990.
9. Huynh T, Tetenes E, Wallace L and Pollak M: In vivo inhibition of insulin-like growth factor 1 gene expression by tamoxifen. Cancer Res 53: 1727-1730, 1993.
10. Gagliardi A and Collins DC: Inhibition of angiogenesis by antiestrogens. Cancer Res 53: 533-535, 1993.
11. Hennig B, Shasby DM, Fulton AB and Spector AA: Exposure to free fatty acids increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis 4: 489, 1984.
12. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC and Lawley TJ: HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690, 1992.
13. Lees MB and Paxman S: Modification of the Lowry procedure for the analysis of proteolipid protein. Anal Biochem 47: 184-192, 1972.
14. LaBarca C and Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
15. Lerner L and Jordan V: Development of antiestrogens and their use in breast cancer. Eighth Cain Memorial Award Lecture, Cancer Res 50: 4177-4189, 1990.
16. Furman Haran E, Maretzek AF and Degani H: Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 54: 5511-5514, 1994.
17. Tavares JA, Stamford IF and Bennett A: Tamoxifen inhibits 5-lipoxygenase in human polymorphonuclear leucocytes. J Pharm Pharmacol 39: 323-324, 1987.
18. Gamier M, Mesange F, Dupont M-A, Gas N, Zanibellato C, Bayard F and Faye J-C: Ligands of the antiestrogen binding site block endothelial cell proliferation reversibly. Exp Cell Res 205: 191-194, 1993.
19. Delhlefsen SM, Shepro D and D'Amore PA: Arachidonic acid metabolites in bFGF-, PDGF-, and serum stimulated vascular cell growth. Exp Cell Res 212: 262-273, 1994.
20. Fafeur V, Jiang ZP and Bohlen P: Signal transduction by bFGF. but not TGFB1. involves arachidonic acid metabolism in endothelial cells J Cell Physiol 149: 277-283, 1991
21. Hoh YK, Lim EH, Ooi SO and Kon OL: Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells. Experientia 46: 1032-1037, 1990.
22. Ritchie GAF. In: Endocrine Treatment of Breast Cancer (Henningsen B, Lindner F and Steichel C, eds.), Heidelberg, Springer Verlag, 1980.
23. Sutherland RL, Watts CK and Ruenitz PC: Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytnphenylethylenes with high affinity for the estrogen receptor. Biochem Biophy Res Comm 140: 523-529, 1986.
24. Pavlik E, Nelson K, Srinivasan S, Meares K, van Nagell, Jr. J. DePriest PD, Gallion HS, van Nagell, III J and Kenady DE: The pure antiestrogen ICI-164384 interacts with estrogen receptors and non-estrogen receptor molecules in rodent and human preparations. Endocrine J 1: 147-155, 1993.
25. Chalbos D, Philips A, Galtier F and Rochefort H: Synthetic antiestrogens modulate induction of pS2 and cathepsin-D mRNA by growth factors, and adenosine 3',5'-monophosphate in MCF-7 cells. Endocrinology 133: 571-576, 1993.
26. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
27. Weidner N, Semple JP, Welch WR and Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
28. Harris AL, Horak E, Leek R, Bicknell R, Relf M, Smith K, Greenall M, Kuzu I and Gatter KC: Quantitative angiogenesis in human breast cancer - correlation with lymph node metastasis and assessment of vascular growth factors. Proc Amer Assoc Cancer Res 33: 75, 1992.
29. Macchiarini P, Fontanim G, Hardin MJ, Squartini F and Angeletti CA: Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340: 145-146, 1992.